Specifically matched for Japanese pharmaceutical formulations, offering trace-level impurity control and full GMP trace documentation.
The Japanese pharmaceutical sector is globally recognized for its uncompromising safety requirements, governed strictly by the Pharmaceuticals and Medical Devices Agency (PMDA). As Japan's aging demographic increases demand for cardiovascular, metabolic, and oncology therapeutics, the domestic supply chain faces structural pressure to deliver highly pure Active Pharmaceutical Ingredients (APIs) and advanced synthetic intermediates.
In response, Japanese formulation developers are shifting away from traditional domestically manufactured raw materials to secure global partnerships, particularly with specialized Chinese synthesis plants. By optimizing high-yield chemical synthesis and chiral processing methodologies under ISO and GMP regimes, we serve this gap, guaranteeing low impurity profiles (within ICH Q3A/B limits) and comprehensive supply security.
Advanced HPLC and GC analysis ensure that residual solvents, heavy metals, and chiral impurities are strictly restricted to match the standards of the Japanese Pharmacopoeia (JP).
We provide full foreign manufacturer accreditation assistance and complete documentation pathways to facilitate PMDA Drug Master File (DMF) submissions.
Continuous process optimization from small-scale glass reactors to pilot plant scaling ensures batch consistency.
We leverage asymmetric catalytic processes to isolate enantiomers, such as (R)-(-)-3-chloro-1,2-propanediol, ensuring optimal biological activity and minimized toxicological footprint.
Strict parameter monitoring of cooling, crystallization, and solvent ratios allows control over polymorphic forms (e.g., in Bismuth Subnitrate and 3-Chlorophthalic Anhydride), optimizing dissolution rates.
Integrating in-line analytical technology (PAT) inside our production setups prevents batch deviation, matching the modern digital manufacturing trends demanded by Japan's top-tier buyers.
Essential materials supporting complete laboratory operations and specialized chemical compounding plants.
Shanxi Kawsana Health Co., Ltd. is a professional manufacturer and global supplier of natural botanical extracts, herbal ingredients, and functional health products. With more than 10 years of industry experience, we are committed to providing high-quality plant-based ingredients and comprehensive OEM/ODM solutions for customers worldwide.
Located in Shanxi Province, China, our company operates modern production facilities equipped with advanced extraction, purification, concentration, and drying technologies. Our GMP-compliant manufacturing workshop covers over 12,000 square meters, supported by a 600-square-meter R&D and Quality Control Center. Backed by an experienced team of production technicians, R&D specialists, and quality management professionals, we ensure every product meets stringent international quality standards.
To better serve our global partners, we provide one-stop solutions covering product development, customized formulations, ingredient sourcing, laboratory testing, quality documentation, private labeling, packaging design, regulatory support, and international logistics. Whether you require bulk ingredients or finished products, our professional team is dedicated to delivering reliable, efficient, and customized services.
Quality is the cornerstone of our business. Every batch undergoes rigorous testing using advanced analytical instruments such as HPLC, UV, GC, and microbiological analysis to ensure purity, potency, safety, and consistency. Our quality management system complies with international standards, enabling us to meet the requirements of customers in highly regulated markets.
Today, Shanxi Kawsana Health Co., Ltd. exports its products to more than 40 countries and regions, including Europe, North America, South America, Australia, Southeast Asia, the Middle East, and Russia. Through continuous innovation, strict quality control, and customer-oriented service, we have established long-term partnerships with pharmaceutical companies, dietary supplement manufacturers, and distributors around the world.
Japanese Market Logistics Route
Fast export routing via Tianjin/Qingdao ports to Osaka, Tokyo, and Yokohama. Complete cold-chain, humidity control, and export customs clearance handling.
A pictorial insight into our GMP-compliant operational workflows and testing labs.
Connecting regional raw material stability with optimized international freight pathways to Japan.
Through our integrated facilities in Shanxi, we manage critical upstream supply chains, shielding our Japanese partners from raw material pricing fluctuations and regional transport bottlenecks.
A broad array of chemical and natural APIs matching global and local pharmacopoeia requirements.
Ensuring clear regulatory compliance, risk-reduced imports, and expert technical documentation.
We supply complete Dossiers, Residual Solvent Studies (ICH Q3C), Elemental Impurities Reports (ICH Q3D), and Certificate of Analysis (CoA) for each shipped batch.
Navigating the PMDA approval process requires experienced documentation management. We provide full support to our Japanese counterparts by preparing files according to Common Technical Document (CTD) requirements.
Our instruments (Agilent HPLC, GC, Shimadzu spectrophotometers) are calibrated regularly under strict ALCOA+ principles to guarantee raw data integrity.
Retention samples for all API batches exported to Japan are securely stored in climate-controlled archives for five years to allow easy tracking.
Addressing the common operational, chemical, and logistics questions from Japanese procurement managers.
Optimize your supply chain with our high-purity API compounds, custom synthesis capacities, and dedicated regulatory support.
Send Inquiry Now
Kawsana Health
